Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study by Bruno Emond, Carmine Rossi, Aurélie Côté-Sergent, Keith Dunn, Patrick Lefebvre, Marie-Hélène Lafeuille, Prina Donga

“…**Objectives:** To describe demographic and clinical characteristics of insured patients with HIV-1 in the United States initiating darunavir/​cobicistat/​emtricitabine/​tenofovir alafenamide (DRV/c/FTC/TAF) or bictegravir/FTC/TAF (BIC/FTC/TAF), assess the differences in weight and body mass index (BMI) change between cohorts up to one year after treatment initiation, and identify the predictors of weight gain associated with each treatment. …”
Get full text

Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV by Pierre-Emmanuel Plum, Nathalie Maes, Anne-Sophie Sauvage, Frédéric Frippiat, Christelle Meuris, Françoise Uurlings, Marianne Lecomte, Philippe Léonard, Nicolas Paquot, Karine Fombellida, Dolores Vaira, Michel Moutschen, Gilles Darcis

Subjects: “…Tenofovir alafenamide…”
Get full text

Approaches to tenofovir and abacavir drug shortages in South Africa: A guide for clinicians by Laurie Schowalter, Francesca Conradie

“…Shortages of the nucleoside reverse transcriptase inhibitors (NRTI) abacavir and tenofovir have been reported recently at health facilities across South Africa. …”
Get full text

Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide by Franco Maggiolo, Daniela Valenti, Rodolfo Teocchi, Laura Comi, Elisa Di Filippo, Marco Rizzi

“…We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide. Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy of adherence. …”
Get full text

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults by Wissam K. Kabbara, Wijdan H. Ramadan

“…Summary: This paper reviews the current literature and information on the combination drug Complera™ (rilpivirine/emtricitabine/tenofovir disoproxil fumarate) that was approved by the Food and Drug Administration (FDA) in August 2011.PubMed, Cochrane and Embase (2001–2014) were searched for primary and review articles on rilpivirine, emtricitabine, and tenofovir disoproxil fumarate, individually or in combination. …”
Get full text

A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B by Dongwoo Kim, Jongjin Lee, Dae-ha Kim, Kyuho Kang, Sang Jun Suh, Young Kul Jung, Hyung Joon Yim

Subjects: “…Tenofovir…”
Get full text

Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report by Di Biagio Antonio, Rosso Raffaella, Monteforte Patrizia, Russo Rodolfo, Rovetta Guido, Viscoli Claudio

“…<p>Abstract</p> <p>Introduction</p> <p>Tenofovir disoproxil fumarate (Viread^®) is the only nucleotide reverse transcriptase inhibitor currently approved for the treatment of HIV. …”
Get full text

Association of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected Patients by Ruijun Chen, Rebecca Scherzer, Priscilla Y. Hsue, Vasantha Jotwani, Michelle M. Estrella, Michael A. Horberg, Carl Grunfeld, Michael G. Shlipak

Subjects: Get full text

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. by J Gerardo García-Lerma, Ron A Otten, Shoukat H Qari, Eddie Jackson, Mian-Er Cong, Silvina Masciotra, Wei Luo, Caryn Kim, Debra R Adams, Michael Monsour, Jonathan Lipscomb, Jeffrey A Johnson, David Delinsky, Raymond F Schinazi, Robert Janssen, Thomas M Folks, Walid Heneine

“…Group 1 was treated subcutaneously with a human-equivalent dose of emtricitabine (FTC), group 2 received orally the human-equivalent dosing of both FTC and tenofovir-disoproxil fumarate (TDF), and group 3 received subcutaneously a similar dosing of FTC and a higher dose of tenofovir. …”
Get full text

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆ by Ming-Lun Yeh, Po-Cheng Liang, Sam Trinh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H. Nguyen, Ming-Lung Yu

Subjects: “…Tenofovir alafenamide…”
Get full text

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B? by Hyung Joon Yim

Subjects: Get full text

Linking the Population Pharmacokinetics of Tenofovir and Its Metabolites With Its Cellular Uptake and Metabolism by K Madrasi, R N Burns, C W Hendrix, M J Fossler, A Chaturvedula

“…Empirical pharmacokinetic models are used to explain the pharmacokinetics of the antiviral drug tenofovir (TFV) and its metabolite TFV diphosphate (TFV‐DP) in peripheral blood mononuclear cells. …”
Get full text

Clinical Images: Tenofovir‐Induced Fanconi Syndrome: An Uncommon Cause of Hypophosphatemic Osteomalacia by Rasmi Ranjan Sahoo, Anupam Wakhlu

Get full text

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. by Lisa C Rohan, Bernard J Moncla, Ratiya Pamela Kunjara Na Ayudhya, Marilyn Cost, Yunda Huang, Fang Gai, Nicole Billitto, J D Lynam, Kara Pryke, Phillip Graebing, Nicole Hopkins, James F Rooney, David Friend, Charlene S Dezzutti

“…To validate our findings with on-going clinical trial results, we evaluated topical tenofovir gel for safety and efficacy. We also modeled systemic application of tenofovir for efficacy.Formulation assessment of tenofovir gel included osmolality, viscosity, in vitro release, and permeability testing. …”
Get full text

Acquired Fanconi Syndrome from Tenofovir Treatment in a Patient with Hepatitis B by Shirley X. Jiang, John Duncan, Hin Hin Ko

“…Finally, persistent electrolyte derangements led to urine studies, which demonstrated acquired Fanconi syndrome secondary to tenofovir. After discontinuing tenofovir disoproxil fumarate and starting tenofovir alafenamide, her symptoms resolved and her renal function recovered. …”
Get full text

Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir by Daniel Yilma, Alemseged Abdissa, Pernille Kæstel, Markos Tesfaye, Mette F. Olsen, Tsinuel Girma, Christian Ritz, Henrik Friis, Åse B. Andersen, Ole Kirk

Subjects: Get full text

Cost-effectiveness of tenofovir alafenamide and entecavir in chronic hepatitis B in Saudi Arabia by Ahmed Al-Jedai

Get full text

Adenosine Deaminase as a Biomarker of Tenofovir Mediated Inflammation in Naïve HIV Patients by Francisco Miguel Conesa-Buendía, Patricia Llamas-Granda, Patricia Atencio, Alfonso Cabello, Miguel Górgolas, Raquel Largo, Gabriel Herrero-Beaumont, Aránzazu Mediero

Subjects: “…tenofovir…”
Get full text

Tenofovir over Entecavir on Hepatocellular Carcinoma Prevention: Potential Mechanisms and Suitable Population by Yongfa Huang, Huayu Yang, Yilei Mao

Get full text

Bilateral atraumatic neck of femur fractures secondary to tenofovir-induced fanconi syndrome by Vikaesh Moorthy, Kelvin Guoping Tan

Subjects: Get full text